Further analysis showed that women with the CC genotype of IGFBP-3 A-202C had a 16-fold higher risk of breast cancer compared to those with other genotypes (OR=16.237; 95%CI 7.904, 33.356, p ≤ 0.001). This evidence concerns the gene IGFBP3 and breast carcinoma.